Atrium Therapeutics, Inc. Company Profile
Atrium Therapeutics, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 3020 CALLAN ROAD, SAN DIEGO, California, 92121, United States.
- Mailing address: Value 3020 CALLAN ROAD, SAN DIEGO, California, 92121, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 3020 CALLAN ROAD, SAN DIEGO, California, 92121, United States |
| Mailing address | 3020 CALLAN ROAD, SAN DIEGO, California, 92121, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Common Stock, par value $0.001 per share · RNA · Nasdaq Global Select Market 10-Q filed 2026-08-13 cover |
| Shell company | No 10-Q filed 2026-08-13 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-13 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-13 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-13 cover |
| First EDGAR filing | 2025-12-10 (10-12B) |
| SEC CIK | 2093101 |
| EIN | 000000000 |
| Phone | 858-401-7900 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |